CS183616B2 - Method for producing therapeutically active complex compound of inosine - Google Patents

Method for producing therapeutically active complex compound of inosine

Info

Publication number
CS183616B2
CS183616B2 CS7000005929A CS592970A CS183616B2 CS 183616 B2 CS183616 B2 CS 183616B2 CS 7000005929 A CS7000005929 A CS 7000005929A CS 592970 A CS592970 A CS 592970A CS 183616 B2 CS183616 B2 CS 183616B2
Authority
CS
Czechoslovakia
Prior art keywords
inosine
complex compound
therapeutically active
active complex
producing therapeutically
Prior art date
Application number
CS7000005929A
Other languages
Czech (cs)
English (en)
Inventor
Paul Gordon
Original Assignee
Paul Gordon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Gordon filed Critical Paul Gordon
Publication of CS183616B2 publication Critical patent/CS183616B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS7000005929A 1969-08-28 1970-08-28 Method for producing therapeutically active complex compound of inosine CS183616B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85386469A 1969-08-28 1969-08-28

Publications (1)

Publication Number Publication Date
CS183616B2 true CS183616B2 (en) 1978-07-31

Family

ID=25317098

Family Applications (1)

Application Number Title Priority Date Filing Date
CS7000005929A CS183616B2 (en) 1969-08-28 1970-08-28 Method for producing therapeutically active complex compound of inosine

Country Status (24)

Country Link
US (1) US3646007A (xx)
JP (2) JPS493999B1 (xx)
AT (1) AT299457B (xx)
BE (1) BE755361A (xx)
BR (1) BR6915483D0 (xx)
CA (1) CA920125A (xx)
CH (1) CH530998A (xx)
CS (1) CS183616B2 (xx)
DE (2) DE1965431C3 (xx)
DK (1) DK137801B (xx)
ES (1) ES375387A1 (xx)
FR (1) FR2068522B1 (xx)
GB (1) GB1252401A (xx)
HU (1) HU162297B (xx)
IL (1) IL35135A (xx)
LU (1) LU61603A1 (xx)
NL (1) NL140735B (xx)
NO (1) NO126800B (xx)
PH (2) PH9221A (xx)
PL (1) PL80960B1 (xx)
SE (1) SE384866B (xx)
SU (1) SU381216A3 (xx)
YU (1) YU36188B (xx)
ZA (1) ZA705913B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2260331B1 (xx) * 1974-02-08 1978-01-13 Mauvernay Centre Europ Rech
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4387226A (en) * 1981-08-26 1983-06-07 Newport Pharmaceuticals International, Inc. Purine-dihydrothiazoles
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
JPS5994567U (ja) * 1982-12-15 1984-06-27 松下電工株式会社 折り畳みドアのラツチ構造
US4512981A (en) * 1982-12-20 1985-04-23 Newport Pharmaceuticals International, Inc. Method of treating inflammation using inosiplex
DE3404315C1 (de) * 1984-02-08 1985-05-09 Newport AG, Zug Verwendung von Inosin-haltigen Wirkstoffen zur Wachstumsfoerderung bei der Mast von Nutztieren
FR2652003A1 (fr) * 1989-09-20 1991-03-22 Delalande Sa Utilisation d'un complexe de l'inosine avec un n,n-dialkylamino alcanol ou un sel de celui-ci avec un acide pharmacologiquement acceptable pour le traitement de certaines infections helminthiques.
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN104744541A (zh) * 2014-05-05 2015-07-01 深圳信立泰药业股份有限公司 一种异丙肌苷新晶型、其制备方法及含有该新晶型的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879259A (en) * 1956-11-20 1961-10-11 Riker Laboratories Inc Acid addition salts of 2-dimethylaminoethanol and central nervous system stimulant compositions containing them
US3438968A (en) * 1966-06-23 1969-04-15 Int Chem & Nuclear Corp Substituted ammonium basic addition salts of ribonucleic acid

Also Published As

Publication number Publication date
NL7000574A (xx) 1971-03-02
IL35135A (en) 1974-07-31
BR6915483D0 (pt) 1973-03-13
GB1252401A (xx) 1971-11-03
PH9221A (en) 1975-07-10
DE1967073A1 (de) 1976-12-02
US3646007A (en) 1972-02-29
DE1965431A1 (de) 1971-04-08
SE384866B (sv) 1976-05-24
JPS4921765B1 (xx) 1974-06-04
JPS493999B1 (xx) 1974-01-29
FR2068522B1 (xx) 1974-08-30
BE755361A (fr) 1971-03-01
DE1965431B2 (de) 1978-05-18
AT299457B (de) 1972-06-26
DK137801C (xx) 1978-10-16
YU36188B (en) 1982-02-25
SU381216A3 (xx) 1973-05-15
CH530998A (de) 1972-11-30
LU61603A1 (xx) 1971-08-05
HU162297B (xx) 1973-01-29
DK137801B (da) 1978-05-08
FR2068522A1 (xx) 1971-08-27
DE1965431C3 (de) 1979-01-04
IL35135A0 (en) 1970-10-30
PL80960B1 (en) 1975-08-30
PH10011A (en) 1976-07-13
ZA705913B (en) 1971-04-28
NL140735B (nl) 1974-01-15
YU214570A (en) 1981-04-30
DE1967073C2 (de) 1986-04-17
CA920125A (en) 1973-01-30
ES375387A1 (es) 1972-05-01
NO126800B (xx) 1973-03-26

Similar Documents

Publication Publication Date Title
CS181701B2 (en) Method of producing derivatives of 6-amino-9-arabinofur nosylpurine
JPS5217449A (en) Process for manufacture of 155alkylprostaglandin
JPS5373568A (en) Method of producing pyridine compounds
CS183616B2 (en) Method for producing therapeutically active complex compound of inosine
YU39064B (en) Process for obtaining 8:14-dihydro-thebaine by means of thebaine reduction
CS191158B2 (en) Method of producing substituted 1-phenyl-2-amino alcohols
CS188869B2 (en) Method of producing derivatives of furane-3-carboxamide
CA950849A (en) Process for producing inosine
CS181207B2 (en) Method of producing benzocycloheptaisochinoline derivatives
JPS52138525A (en) Process for manufacture of new triazol compound
JPS53147080A (en) Method of producing fluorouracile compound
CS184309B2 (en) Method of producing novel antibotic
YU292770A (en) Process for producing acyl derivatives of substituted bis-arylalkylamines
CS180570B2 (en) Method for production of erythromycylamines
JPS53127487A (en) Method of producing quinoxalineediinnoxide
CS181249B2 (en) Method of producing alkanolamine derivatives
CA805134A (en) Method for the production of inosine
CA949982A (en) Method of producing 2-chlorobutenes
CA809229A (en) Method of preparing organohalogenosilicon compounds
EG10524A (en) Process for preparation of penicillamin
CA813871A (en) Process for producing inosine
IL34942A0 (en) Method for preparation of macrocyclic compounds
CA836538A (en) Process for the production of inosine
CA809577A (en) Method for manufacture of cyanamide
CA856763A (en) Process for preparation of dichloroethanes